• Login
    About WHOAS
    View Item 
    •   WHOAS Home
    • Marine Biological Laboratory
    • Josephine Bay Paul Center in Comparative Molecular Biology and Evolution
    • View Item
    •   WHOAS Home
    • Marine Biological Laboratory
    • Josephine Bay Paul Center in Comparative Molecular Biology and Evolution
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of WHOASCommunities & CollectionsBy Issue DateAuthorsTitlesKeywordsThis CollectionBy Issue DateAuthorsTitlesKeywords

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis

    Thumbnail
    View/Open
    WHOAS_JCF-D-13-00155R2[1].pdf (582.4Kb)
    Date
    2013-10
    Author
    Gifford, Alex H.  Concept link
    Alexandru, Diana M.  Concept link
    Li, Zhigang  Concept link
    Dorman, Dana B.  Concept link
    Moulton, Lisa A.  Concept link
    Price, Katherine E.  Concept link
    Hampton, Thomas H.  Concept link
    Sogin, Mitchell L.  Concept link
    Zuckerman, Jonathan B.  Concept link
    Parker, H. Worth  Concept link
    Stanton, Bruce A.  Concept link
    O'Toole, George A.  Concept link
    Metadata
    Show full item record
    Citable URI
    https://hdl.handle.net/1912/6406
    As published
    https://doi.org/10.1016/j.jcf.2013.11.004
    Keyword
     Hypoferremia; Anemia; Cystic fibrosis; Iron; Hepcidin-25; Microbiome 
    Abstract
    Iron supplementation for hypoferremic anemia could potentiate bacterial growth in the cystic fibrosis (CF) lung, but clinical trials testing this hypothesis are lacking. Twenty-two adults with CF and hypoferremic anemia participated in a randomized, double-blind, placebo-controlled, crossover trial of ferrous sulfate 325 mg daily for 6 weeks. Iron-related hematologic parameters, anthropometric data, sputum iron, Akron Pulmonary Exacerbation Score (PES), and the sputum microbiome were serially assessed. Fixed-effect models were used to describe how ferrous sulfate affected these variables. Ferrous sulfate increased serum iron by 22.3% and transferrin saturation (TSAT) by 26.8% from baseline (p < 0.05) but did not affect hemoglobin, sputum iron, Akron PES, and the sputum microbiome. Low-dose ferrous sulfate improved hypoferremia without correcting anemia after 6 weeks. We did not observe significant effects on sputum iron, Akron PES, and the sputum microbiome. Although we did not identify untoward health effects of iron supplementation, a larger blinded randomized controlled trial would be needed to fully demonstrate safety.
    Description
    Author Posting. © The Author(s), 2013. This is the author's version of the work. It is posted here by permission of Elsevier for personal use, not for redistribution. The definitive version was published in Journal of Cystic Fibrosis 13 (2014): 311-318, doi:10.1016/j.jcf.2013.11.004.
    Collections
    • Josephine Bay Paul Center in Comparative Molecular Biology and Evolution
    Suggested Citation
    Preprint: Gifford, Alex H., Alexandru, Diana M., Li, Zhigang, Dorman, Dana B., Moulton, Lisa A., Price, Katherine E., Hampton, Thomas H., Sogin, Mitchell L., Zuckerman, Jonathan B., Parker, H. Worth, Stanton, Bruce A., O'Toole, George A., "Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis", 2013-10, https://doi.org/10.1016/j.jcf.2013.11.004, https://hdl.handle.net/1912/6406
     

    Related items

    Showing items related by title, author, creator and subject.

    • Thumbnail

      The microbiome in pediatric cystic fibrosis patients : the role of shared environment suggests a window of intervention 

      Hampton, Thomas H.; Green, Deanna M.; Cutting, Garry R.; Morrison, Hilary G.; Sogin, Mitchell L.; Gifford, Alex H.; Stanton, Bruce A.; O’Toole, George A. (BioMed Central, 2014-04-28)
      Cystic fibrosis (CF) is caused by mutations in the CFTR gene that predispose the airway to infection. Chronic infection by pathogens such as Pseudomonas aeruginosa leads to inflammation that gradually degrades lung function, ...
    • Thumbnail

      Profiling of bacterial and fungal microbial communities in cystic fibrosis sputum using RNA 

      Grahl, Nora; Dolben, Emily L.; Filkins, Laura M.; Crocker, Alex W.; Willger, Sven D.; Morrison, Hilary G.; Sogin, Mitchell L.; Ashare, Alix; Gifford, Alex H.; Jacobs, Nicholas J.; Schwartzman, Joseph D.; Hogan, Deborah A. (American Society for Microbiology, 2018-08-08)
      Here, we report an approach to detect diverse bacterial and fungal taxa in complex samples by direct analysis of community RNA in one step using NanoString probe sets. We designed rRNA-targeting probe sets to detect 42 ...
    • Thumbnail

      Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis Lung Disease 

      Hogan, Deborah A.; Willger, Sven D.; Dolben, Emily L.; Hampton, Thomas H.; Stanton, Bruce A.; Morrison, Hilary G.; Sogin, Mitchell L.; Czum, Julianna; Ashare, Alix (Public Library of Science, 2016-03-04)
      Individuals with cystic fibrosis (CF) often acquire chronic lung infections that lead to irreversible damage. We sought to examine regional variation in the microbial communities in the lungs of individuals with mild-to-moderate ...
    All Items in WHOAS are protected by original copyright, with all rights reserved, unless otherwise indicated. WHOAS also supports the use of the Creative Commons licenses for original content.
    A service of the MBLWHOI Library | About WHOAS
    Contact Us | Send Feedback | Privacy Policy
    Core Trust Logo